OYRDX | VTSAX | OYRDX / VTSAX | |
Total Expense Ratio | 0.73 | 0.04 | 1,825% |
Annual Report Gross Expense Ratio | 0.73 | 0.04 | 1,825% |
Fund Existence | 28 years | 25 years | - |
Gain YTD | 2.777 | 1.138 | 244% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.17B | 1.72T | 0% |
Annual Yield % from dividends | 1.11 | 1.36 | 81% |
Returns for 1 year | 0.10 | 11.69 | 1% |
Returns for 3 years | 22.09 | 50.42 | 44% |
Returns for 5 years | 45.01 | 97.68 | 46% |
Returns for 10 years | 41.14 | 176.15 | 23% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SLVYX | 25.44 | N/A | N/A |
Saratoga Large Capitalization Value A | |||
PSGIX | 20.60 | N/A | N/A |
BlackRock Advantage Small Cap Gr Instl | |||
BRGAX | 37.96 | N/A | N/A |
iShares Russell 1000 Large-Cap Idx Inv A | |||
SHSAX | 61.04 | N/A | N/A |
BlackRock Health Sciences Opps Inv A | |||
NWAVX | 14.64 | -0.01 | -0.07% |
Nationwide GQG US Quality Eq R6 |